In Vitro Diagnostics: Technologies and Global Markets
상품코드:1642869
리서치사:BCC Research
발행일:2025년 01월
페이지 정보:영문 159 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 체외진단(IVD) 시장 규모는 2024년 947억 달러에서 예측 기간 동안 연평균 8.4%로 성장하여 2029년 말에는 1,419억 달러에 달할 것으로 예상됩니다.
면역화학 IVD 시장은 2024년 328억 달러에서 예측 기간 동안 CAGR 5.5%, 2029년 말까지 430억 달러에 달할 것으로 예상되며, POC 검사 IVD 시장은 2024년 232억 달러에서 CAGR 10.6%, 2029년 말까지 384억 달러에 달할 것으로 예상됩니다. 말에는 384억 달러에 달할 것으로 예상됩니다.
세계의 체외진단(IVD) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규제 환경, 신흥 기술 및 기술 개발 동향, 시장 규모 추정과 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장과 기술 배경
체외진단(IVD) 기술
개요
IVD 엘리먼트 분류
IVD 기술과 품질 관리의 중요성
IVD와 생체 진단의 차이
IVD 업계 규제
각국의 IVD 제품 규제
제3장 시장 역학
개요
시장 성장 촉진요인
노인 인구 증가 : 진단 처치에 대한 의존
IVD에서 AI의 통합
만성질환 만연
Point of Care 검사(POCT) 품질 향상
시장 성장 억제요인
기술 제품 패키징 관련 과제
배송 비용 증가와 서비스 문제
실험 조수의 실험 기구나 소모품 취급 능력 결여
시장 기회
재택 케어 검사 디바이스 증가
POCT 유닛 수요
AI와 IoT에 대한 수요 상승
제4장 신기술과 개발
IVD 시장의 신기술
AI
개선된 오래된 IVD 기술
액체 생검
자동 IVD 디바이스
IVD의 새로운 발전
FDA 승인
맞춤형 의료 수요 증가
실험실 자동화와 디지털 헬스 플랫폼
IVD 디바이스의 휴대성 옵션
암 진단을 위한 홈케어 키트
FDA 승인 IVD 디바이스 : AI 대응
제5장 시장 세분화 분석
세분화 내역
시장 분석 : 기술별
면역화학
POC 테스트
혈액
분자진단
조직 진단
임상 미생물
시장 분석 : 용도별
당뇨병
신장
혈당치 평가와 모니터링(BGEM)
종양
심장병
감염증
기타
시장 분석 : 최종사용자별
진단 실험실
병원·진료소
POC 센터
기타
지역적 내역
시장 분석 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
제6장 경쟁 정보
세계의 기업 순위 분석
중국의 주요 IVD 기업 개요
협정, 협력, 파트너십
IVD 기업과 스타트업
제7장 체외진단(IVD) 업계의 지속가능성 : ESG 관점
IVD 제조 업계의 ESG의 중요성
IVD 업계의 ESG 실천
환경 퍼포먼스
사회적 퍼포먼스
거버넌스 퍼포먼스
ESG 개발의 기업의 역할
ESG 리스크 평가
BCC에 의한 견해
제8장 부록
조사 방법
참고문헌
기업 개요
ABBOTT
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
JSR CORP.
QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.
ksm
영문 목차
영문목차
The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
The immunochemistry IVD market is expected to grow from $32.8 billion in 2024 and is projected to reach $43.0 billion by the end of 2029, at a CAGR of 5.5% during the forecast period of 2024 to 2029.
The POC testing IVD market is expected to grow from $23.2 billion in 2024 and is projected to reach $38.4 billion by the end of 2029, at a CAGR of 10.6% during the forecast period of 2024 to 2029.
Report Scope
This report covers the in vitro diagnostic (IVD) technologies as well as in vitro diagnostic devices used in hospitals and point-of-care (POC) facilities to diagnose diseases. It also details the current and future market potential of in vitro diagnostic technology and includes an analysis of this market's competitive environment. The report covers market drivers, restraints, opportunities, product approvals, regulatory scenario assessments and emerging technologies. It features market projections and estimates of the market shares of key players through 2029.
In this analysis, the in vitro diagnostics market is segmented based on technologies, applications, end users and region. Based on technologies, the market is segmented into the following categories: hematology, immunochemistry, molecular diagnostics, POC testing, clinical microbiology and tissue diagnostics. Based on applications, the in vitro diagnostics market is segmented into these categories: diabetes, nephrology, blood glucose evaluation and monitoring (BGEM), oncology, cardiology, infectious diseases and other applications. The market is segmented based on end users into diagnostic laboratories, hospitals and clinics, point-of-care centers, and other end users.
The global in vitro diagnostics market has been segmented by the following geographical regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report features detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Australia and New Zealand (ANZ), Argentina, Brazil, South Africa, Mexico and the GCC countries. Market analysis data is provided for 2023, which serves as the base year, and estimates are given for 2024 and forecast values through 2029.
Report Includes
41 data tables and 54 additional tables
Analysis of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimates of the size of the market for in vitro diagnostics (IVD) technologies, revenues, and market shares by technology, product, application, end user and region
Assessment of market dynamics such as drivers, restraints and opportunities
Discussion of how the rise in the number of respiratory infections, hospital acquired infections (HAIs), and sexually transmitted diseases are creating a constant need for IVD testing in hospitals and laboratories
Discussion of IVD for neglected infectious diseases, chemistry-based portable analysis and microfluidic platform-based POC tests
A discussion on ESG challenges and practices in the industry
Assessment of the competitive landscape, including the market shares of key companies, their product portfolios and financial overviews
Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments and product launches
Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Abbott, Sysmex Corp., Danaher, BD, and Siemens Healthineers AG
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market and Technology Background
Introduction
In vitro Diagnostics Technology
Overview
Classification of In Vitro Diagnostic Elements
Importance of In Vitro Diagnostics Technologies and Quality Control
Difference Between In Vitro and In Vivo Diagnostics
Regulations in the IVD Industry
Regulation of IVD Products in Different Countries
Chapter 3 Market Dynamics
Overview
Market Drivers
Rise in Population of Older Adults: Dependence on Diagnosis Procedures
Integration of Artificial Intelligence in Vitro Diagnostics
Rising Prevalence of Chronic Diseases
Improving the Quality of Point-of-Care Testing (POCT)
Market Restraints
Challenges Associated with Technologies Product Packaging
Increases in Shipping Costs or Service Issues
Laboratory Assistant's Inability to Handle Laboratory Equipment and Consumables
Market Opportunities
Rise in Home Care Testing Devices
Demand for Point-of-Care (POC) Testing Units
Growing Demand for AI and the Internet of Things
Chapter 4 Emerging Technologies and Developments
Emerging Technologies in the IVD Market
Artificial Intelligence
Modified Old IVD Techniques
Liquid Biopsy
Automated In Vitro Diagnostic Devices
Emerging Developments in In Vitro Diagnostics
FDA Approval
Rise in Demand for Personalized Medicine
Lab Automation and Digital Health Platform
Portability Option in IVD Devices
Home Care Kits for Cancer Diagnosis
FDA Approved In Vitro Diagnostic Devices: AI Enabled
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Technology
Immunochemistry
POC Testing
Hematology
Molecular Diagnostics
Tissue Diagnostics
Clinical Microbiology
Market Analysis by Application
Diabetes
Nephrology
Blood Glucose Evaluation and Monitoring (BGEM)
Oncology
Cardiology
Infectious Diseases
Other Applications
Market Analysis by End User
Diagnostic Laboratory
Hospitals and Clinics
Point-of-Care (POC) Centers
Other End Users
Geographical Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Chapter 6 Competitive Intelligence
Introduction
Global Analysis of Company Market Ranking
Glimpse of Leading In Vitro Diagnostics (IVD) Companies in China
Agreements, Collaborations and Partnerships
bioMerieux Agreements
Siemens Healthineers and Sysmex Enter into a Global Agreement
Roche Enters into Agreement with Path AI
Quidel Corp. Signs Agreement to Acquire Ortho Clinical Diagnostics
In Vitro Diagnostics Companies and Start-Ups in 2021-2023
Diagopreutic Private Limited
Diatherax
IPLEXMED
Magnify Bioscience Inc.
Chapter 7 Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
Importance of ESG in In Vitro Diagnostics Manufacturing Industry
ESG Practices in the In Vitro Diagnostics Industry
